Roosevelt Investment Group’s Biogen BIIB Stock Holding History

Roosevelt Investment Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-82,760	Closed	-$24.1M	–	223
2015 Q3	$24.1M	Sell	82,760 -6,932	-8%	-$2.29M	1.57%	24
2015 Q2	$36.2M	Sell	89,692 -2,124	-2%	-$852K	2.14%	12
2015 Q1	$38.7M	Buy	91,816 +8,687	+10%	+$3.42M	2.11%	12
2014 Q4	$28.2M	Sell	83,129 -85,938	-51%	-$27.8M	1.58%	21
2014 Q3	$55.9M	Sell	169,067 -100,548	-37%	-$33.2M	2.98%	4
2014 Q2	$85M	Buy	269,615 +27,637	+11%	+$8.32M	3.62%	3
2014 Q1	$74M	Sell	241,978 -2,379	-1%	-$755K	3.43%	2
2013 Q4	$68.3M	Buy	244,357 +21,771	+10%	+$5.63M	3.08%	5
2013 Q3	$53.6M	Sell	222,586 -13,498	-6%	-$3.02M	2.38%	12
2013 Q2	$50.8M	Buy	+236,084	New	+$50.4M	2.28%	10

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Roosevelt Investment Group's BIIB Position: Q4 2015 in Review

Roosevelt Investment Group sold out of Biogen (BIIB) in Q4 2015, closing a stake of 82,760 shares — an estimated $24.1M sold.

Roosevelt Investment Group first reported a position in BIIB in Q2 2013 and held it in 10 quarters. The position peaked at $85M in Q2 2014. 969 funds tracked by Wall St. Rank hold BIIB as of Q4 2015.

Roosevelt Investment Group reported no remaining Biogen position as of Q4 2015 after selling out during the quarter.
Roosevelt Investment Group sold 82,760 Biogen shares in Q4 2015, an estimated $24.1M.
Roosevelt Investment Group first reported a position in Biogen in Q2 2013 and held it in 10 quarters.
Roosevelt Investment Group's Biogen position peaked at $85M in Q2 2014.
969 funds tracked by Wall St. Rank held Biogen as of Q4 2015.

Based on Roosevelt Investment Group's 13F filing for Q4 2015, filed 11 Feb 2016.